| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H24N2O |
| Molecular Weight | 176.2997 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 2 |
SHOW SMILES / InChI
SMILES
C[N+](C)(C)CC(O)C[N+](C)(C)C
InChI
InChIKey=SEOAESNTVSJYIF-UHFFFAOYSA-N
InChI=1S/C9H24N2O/c1-10(2,3)7-9(12)8-11(4,5)6/h9,12H,7-8H2,1-6H3/q+2
| Molecular Formula | C9H23N2O |
| Molecular Weight | 175.2917 |
| Charge | 1 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Prolonium is a quartenary amine derivative. Prolonium iodide has been given by injection as a source of iodine as part of the treatment of thyroid storm and for the pre-operative management of hyperthyroidism. It is marketed in Italy for veterinary use for the treatment of infectious granulomas, in the various forms of actinomycosis actinobacillosis of the tongue, larynx, pharynx, skin and subcutaneous connective tissue.
